Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : email@example.com
|Definition||A neuroma that is characterized as a benign nerve sheath tumor that is composed of Schwann cells.|
|Path||disease disease of cellular proliferation benign neoplasm organ system benign neoplasm nervous system benign neoplasm neuroma neurilemmoma|
|Molecular Profile||Therapy||Indication/Tumor Type||Response Type||Profile Response Detail|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|
|NCT03095248||Phase II||Selumetinib||Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors (SEL-TH-1601)||Recruiting||USA||0|
|NCT04283669||Phase II||Crizotinib||Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas (NF110)||Active, not recruiting||USA||0|
|NCT04374305||Phase II||Brigatinib||Innovative Trial for Understanding the Impact of Targeted Therapies in NF2 (INTUITT-NF2)||Recruiting||USA||0|